Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Arbourmarkon Apr 18, 2021 8:16am
176 Views
Post# 33018467

RE:RE:Except marky

RE:RE:Except marky

Marky, 

Dont let the clowns from the peanut gallery get under your skin. The real investors holding long know the long term catalysts and outcome. You are not a pumper and only post facts. There are few on this board who are the paid bashers trying to create fear to artificially try to manipulate this stock and keep it low for their benefits. They attack you because they know your posts are factual but they like to post negativity and create doubt.


Marky1 wrote:

YukonJezza wrote:
I'm sure he gets paid

No, I do not get paid..I'm only concerned with Facts, nothing else...That's how my medical mind works
FACTS
1) ANTIBE is presenting an Existential threat to all...I repeat all NSAIDS on the market..Who in their right mind would take Naproxen or Aspirin or Ibuprofen and risk dying...no sane person would
2) THE p values for their P2 testing are beyond amazing..These values are real and was created by statiiscians to show uneqivable proof of the thing that they are testing
3) Dr. Stauffer did work for the FDA in the exact department where we will be presenting our results of P3 testing
4) Dr. Haut just completed a 4B$ sale of a company that took him exactly 7 months to complete..Though he is working in the partnership committee I'm sure that he is giving advise to the acquisition people as well
5) Dr. Wallace is a world renowned GI scientist....written ove 500 papers on the H2S science
6) Amalgamation of ATH to ATE is real and going to be completed with weeks
7) dr.W.  dr.L.  Both have their entire, or most of it wealth tied up with the company
Anyways so much more
Peace Out


<< Previous
Bullboard Posts
Next >>